Spruce biosciences inc.

Other-Pharmaceuticals

SPRB


Executive/
Director

Price

  • Last Close
  • $ 0.43
    $ +0.01 1.67 %
    Jan 3, 2025
  • 52-Week High/Low
  • $5.49 - $0.42
  • YTD
  • 0.7%

  • Trading Volume
  • 5,997
  • Market Cap Full
  • $ 17.5M
  • Shares Outstanding
  • 40.7M
    Nov 9, 2023
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Q1 - - - - -5% -31.7% -54.2% 100.9% -73% 0.7%
Q2 - - - - 4% -32.5% -13.4% -2.7% -36.7% -
Q3 - - - - 8% -46.4% -21.3% 5.1% -11% -
Q4 - - - - 43% -27% -19.7% 35.7% -19.4% -
J F M A M J J A S O N D
2025 0.7% - - - - - - - - - - -
2024 24.9% 36.6% -84.2% -10.4% 4.5% -28.2% -2.3% -11% - - - -
    2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
    0%0%0%0%0%0%-82%-75%166%-86%1%

Earnings

2021 2022 2023
Q1 -0.42 -0.5 -0.40
Q2 -0.5 -0.51 -0.32
Q3 -0.49 -0.48 -0.30
Q4 -0.4 -0.47 -
A -1.8 -2 -1.02

Annual Returns

52 Week
High/Low

Annual
Earnings

Chart

Trading Volume

2020 2021 2022 2023
Mar - 23.3 23.5 39.7
Jun - 23.3 23.5 39.7
Sep - 23.4 23.6 40.7
Dec 23.2 23.5 23.6 40.7

Financial Ratios

20222021202020192018
Asset Management
Inventory / Stock Turnover - - - - -
Fixed Asset Turnover - - - - -
Total Asset Turnover - - - - -
Leverage
Debt Ratio - 0.1 - 0.6 -
Debt – Equity Ratio - 0.1 - -1 -
Interest Coverage 47 - -29 - -
Equity multiplier - 0.3 - - -